[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100102642":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":7,"locations":13,"responsibleParty":34,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":43,"sex":44,"minAge":45,"maxAge":7,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":15,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Cedars-Sinai Medical Center","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Shlomo Melmed, MD","Cedars-Sinai Medical Center, Pituitary Center","PRINCIPAL_INVESTIGATOR",[14],{"facility":11,"status":15,"city":16,"state":17,"zip":18,"country":19,"countryCode":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"RECRUITING","Los Angeles","California","90048","United States","US",{"type":22,"coordinates":23},"Point",[24,25],-118.24368,34.05223,{"lat":25,"lon":24},[28,33],{"name":29,"role":30,"phone":31,"phoneExt":7,"email":32},"Daniel Gomez","CONTACT","424-315-2362","daniel.gomez@cshs.org",{"name":10,"role":12,"phone":7,"phoneExt":7,"email":7},{"type":12,"investigatorFullName":10,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Professor of Medicine","100102642","pituitary-tumor-surveillance-pathogenic-correlation-100102642",false,"NCT00599092","Pituitary Tumor Surveillance: Pathogenic Correlation","Pituitary Tumor Surveillance: Pathogenetic Correlation","Inclusion Criteria:\n\n* patients with confirmed pituitary disease\n\nExclusion Criteria:\n\n* patients who do not have confirmed pituitary disease",true,"ALL","18 Years",{"count":47,"type":48},1250,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.",[52],"Pituitary Tumor",[54,55],"pituitary tumor","recurrence","2026-03-19",{"date":58,"type":59},"2026-03-23","ACTUAL",{"date":61,"type":7},"1997-01",{"date":63,"type":48},"2050-12",{"name":5,"class":6},1]